Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Wai Chun Bio-Technology Ltd. ( (HK:0660) ) is now available.
Wai Chun Bio-Technology Ltd. announced the results of its Extraordinary General Meeting (EGM) held on September 17, 2025, where a resolution regarding the issuance of new convertible bonds was unanimously approved. This decision is contingent upon several conditions, including approval from the Hong Kong Stock Exchange and the Grand Court of the Cayman Islands. The approval of this resolution is expected to impact the company’s financial strategy and shareholder value positively.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating within the biotechnology sector. The company is listed on the Hong Kong Stock Exchange and focuses on the development and commercialization of bio-technological products and services.
Average Trading Volume: 357,758
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.95M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.